Navigation Links
Elsevier and ADSA announce winners of first annual Journal of Dairy Science Most Cited Awards
Date:6/22/2011

Section: Physiology and Management
Riekerink, R.G.M.O., H.W. Barkema, D.F. Kelton, and D.T. Scholl. 2008. Incidence rate of clinical mastitis on Canadian dairy farms. J. Dairy Sci. 91(4):1366-1377.
Corresponding author: R. G. M. Olde Riekerink, Department of Health Management, University of Prince Edward Island, Charlottetown, Prince Edward Island, Canada
Full text available at: http://download.journals.elsevierhealth.com/pdfs/journals/0022-0302/PIIS0022030208712645.pdf

Section: Nutrition, Feeding and Calves
Glasser, F., A. Ferlay, and Y. Chilliard. 2008. Oilseed lipid supplements and fatty acid composition of cow milk: a meta-analysis. J. Dairy Sci. 91(12):4687-4703.
Corresponding author: F. Glasser, Institut National de la Recherche Agronomique, Saint-Gens-Champanelle, France
Full text available at: http://download.journals.elsevierhealth.com/pdfs/journals/0022-0302/PIIS0022030208709378.pdf

Section: Genetics and Breeding
VanRaden, P.M. 2008. Efficient methods to compute genomic predictions. J. Dairy Sci. 91(11):4414-4423.
Corresponding author: Paul Van Raden, Animal Improvement Programs Laboratory, Agricultural Research Service, USDA, Beltsville, MD
Full text available at: http://download.journals.elsevierhealth.com/pdfs/journals/0022-0302/PIIS0022030208709901.pdf

(Affiliations listed are at time of publication)

According to Anthony F. Trioli, Publisher, Health Sciences Journals, Elsevier, "We are extremely pleased to partner with the ADSA to confer this award to outstanding contributors to the field of dairy science. Since its inception in 1917, JD
'/>"/>

Contact: Verity C. Kerkhoff
jdsmedia@elsevier.com
31-204-853-310
Elsevier Health Sciences
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Elsevier launches International Journal for Parasitology: Drugs and Drug Resistance
2. Elsevier announces launch of Swarm and Evolutionary Computation
3. Elsevier, EMBL and University of Copenhagen launch new app for SciVerse
4. SCOPE and Elsevier partner to publish Environmental Development
5. Elsevier and the Arabidopsis Information Resource connect research articles
6. Elsevier sponsors launch ceremonies for the International Year of Chemistry
7. Elsevier is the new publisher of Value in Health
8. WebLib develops application for Elseviers SciVerse applications
9. Elsevier offers scientific book content through Google eBooks
10. Elsevier launches SciVerse Applications beta
11. Elsevier sponsors 2010 Semantic Web Challenge
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... China , 31 de julho de 2015 /PRNewswire/ ... (ICG-10, www.icg-10.org ) será realizada pela BGI de 22-25 ... . A conferência está celebrando seu ... em 2006, a ICG se tornou uma das reuniões ... um dos encontros científicos mais dinâmicos, entusiastas e prazerosos. ...
(Date:7/31/2015)... China , 31 de julio de 2015 ... www.icg-10.org ) se celebrará por medio de BGI del 22 al ... . Este año, la conferencia celebra ... ICG se ha convertido en una de las reuniones anuales ... ser una de las reuniones más dinámicas, entusiastas y mejores ...
(Date:7/31/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market and creator of the Wocket® ... 62/198989 for ELECTRONIC CRYPTO-CURRENCY MANAGEMENT METHOD AND ... advance crypto-currencies such as Bitcoin into the consumer market ... to manage all payments.  The technology ...
Breaking Biology News(10 mins):A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4
... Gerton Lab has provided new evidence to clarify the ... required for proper kinetochore function, which plays a critical ... in yeast cells, was published in the most recent ... centromeric nucleosome acts as a guide for the position ...
... have discovered a huge number of new species of ... amid the harsh conditions of the Australian outback. ... new species of invertebrates, which include various insects, small ... led by Professor Andy Austin (University of Adelaide), ...
... a plant in Erie County that has never been recorded ... with the aid of a Mercyhurst College professor on the ... is known to exist in northern U.S. states and in ... until this discovery. WPC scientists found a small population of ...
Cached Biology News:Gerton Lab determines the composition of centromeric chromatin 2Researchers go underground to reveal 850 new species 2Erie County home to plant never before recorded in Pa. 2
(Date:8/27/2015)... MA (PRWEB) , ... August 27, 2015 , ... Inc. ... United States, ranking iLab Solutions as number 1,361 in growth for the three years ... of the top 0.1% fastest-growing privately held organizations in the country. , “We ...
(Date:8/27/2015)... ... August 27, 2015 , ... Proove ... new data on the relationship of genetics and hypertension at the International ... Disease in Vancouver, British Columbia, Canada. The event, which boasts an extensive overview ...
(Date:8/26/2015)... , Aug. 26, 2015  Roka Bioscience, Inc. (NASDAQ: ... providing advanced testing solutions for the detection of foodborne ... present at the Sidoti & Company Emerging Growth Conference ... be held at the New York Marriott Marquis. ... be available through the investor relations section of Roka ...
(Date:8/26/2015)... , Aug. 26, 2015  Platform therapeutic ... it has received a $1.5M Phase II SBIR ... to further develop its therapeutic agent to reduce ... need in end stage renal disease (ESRD) patients ... National Institute of Diabetes and Digestive and Kidney ...
Breaking Biology Technology:iLab Solutions Named to 2015 Inc. 5000 List 2iLab Solutions Named to 2015 Inc. 5000 List 3Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 3Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 2Symic Biomedical Awarded $1.5MM NIH Phase II SBIR Grant to Develop its Proteoglycan Mimetic Therapeutics to Reduce Vascular Access Failures in ESRD 3
... SUNNYVALE, Calif., June 1 Pharmacyclics, Inc. (Nasdaq: ... on Form S-3 with the Securities and Exchange Commission (the ... The rights offering will be made through the distribution of ... stock, par value $0.0001 per share, at a subscription price ...
... ... Generation nonfood Biofuel crops Knowledge Platform ,CJP,s "3rd Global Jatropha Hi-Tech ... all set to provide the most authoritative Knowledge platform for Development ... Priorities to Feed Biodiesel Industry Worldwide. The biodiesel industry has met ...
... and VANCOUVER, May 30 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. ... of a Phase 1 trial presented during an oral ... Annual Meeting. Preliminary results as of April 2009 showed ... addition, OGX-427 demonstrated declines in circulating tumor cells at ...
Cached Biology Technology:Pharmacyclics Files Registration Statement for Rights Offering 2Pharmacyclics Files Registration Statement for Rights Offering 3Pharmacyclics Files Registration Statement for Rights Offering 4Jatrophaworld Training 2009: 2nd Generation nonfood Biofuel crops Knowledge Platform 2Jatrophaworld Training 2009: 2nd Generation nonfood Biofuel crops Knowledge Platform 3Jatrophaworld Training 2009: 2nd Generation nonfood Biofuel crops Knowledge Platform 4OncoGenex Pharmaceuticals Announces OGX-427 Treatment Demonstrates Safety, Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Markers in a Phase 1 Cancer Trial 2OncoGenex Pharmaceuticals Announces OGX-427 Treatment Demonstrates Safety, Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Markers in a Phase 1 Cancer Trial 3OncoGenex Pharmaceuticals Announces OGX-427 Treatment Demonstrates Safety, Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Markers in a Phase 1 Cancer Trial 4OncoGenex Pharmaceuticals Announces OGX-427 Treatment Demonstrates Safety, Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Markers in a Phase 1 Cancer Trial 5
Recombinant Rat PTX2/SAP...
HybriWell™ hybridization sealing system, 22 mm x 22 mm chamber, 0.15 mm deep *set of 100*...
HybriWell™ hybridization sealing system, 20 mm diameter chamber, 0.15 mm deep *set of 100*...
Recombinant Feline IL-5...
Biology Products: